API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Osimertinib Mesylate: Efficacy in EGFR-Mutant NSCLC, Clinical Applications, and Resistance Mechanisms

Osimertinib mesylate treats EGFR-mutant NSCLC, shows good efficacy/PFS, targets CNS mets, but faces C797S/MET resistance.

Aug 27,2025  API

Eltrombopag Olamine in Thrombocytopenia Treatment

Eltrombopag olamine (TPO-R agonist) treats ITP-related thrombocytopenia (adults/≥1y kids), with bioequivalence studies in Chinese.

Aug 26,2025  API

Ethyl Linoleate (LA-EE): Structural and Physicochemical Background for Dermatological and Cosmeceutical Research

Ethyl linoleate has supporting applications in skin care and inflammation control.

Aug 26,2025  API

4-Chlororesorcinol: From Cosmetic Use to Environmental Degradation Studies

4-Chlororesorcinol has practical applications in chemical industry and environment research

Aug 25,2025  API

The Therapeutic Potential of 2′-Deoxycytidine

2′-Deoxycytidine has tremendous potential in medical applications.

Aug 22,2025  API

Diethylene Glycol Methyl Ethyl Ether: Properties, Synthesis, and Applications

Diethylene glycol methyl ethyl ether has broad industrial relevance and significant potential for future development.

Aug 21,2025  API

An Overview of 4-Chlorophenylacetic Acid

An overview of 4-Chlorophenylacetic acid in pharmaceutical synthesis and environmental studies.

Aug 21,2025  API

Synthesis and Application Research of 1,6-dibromohexane

Due to the particular chemical structure, 1-6-dibromohexane can be applied in copolycondensation and studied in electrochemical reduction.

Aug 19,2025  API

3-Butyn-1-ol: Terminal Alkynol Synthons and Applications in Material Functionalization

3-Butyn-1-ol is a terminal alkynol with high synthetic versatility and broad application potential in both cyclocarbonylation and hydroalumination reactions.

Aug 19,2025  API

Idoxuridine: Antiviral Activity, Applications, and Limitations

Idoxuridine acts against HSV topically but has systemic toxicity; it's replaced by newer drugs, with limited efficacy in genital herpes.

Aug 13,2025  API
Prev12345678910...Next>  Go to Page